Digital Endpoints Resource Guides

Establishing clinical benefit is one of the most challenging and costly steps in developing new treatments. Conventional clinical outcome assessments may lack the sensitivity to detect meaningful changes in patient functioning, but digital endpoints offer new opportunities to advance drug development.

Digital Endpoints

Enhancing Clinical Research with Wearable DHTs

The ActiGraph team has developed these Digital Endpoint Resource Guides to support clinical teams interested in how DHTs can enhance their development programs in specific therapeutic areas. In these guides you will learn:

Clinical Trials

Accelerate Clinical Trials

Opportunities to support drug development in specific therapeutic areas with wearable-based digital endpoints

Hours of Data

Unlock Clinical Insights

Previously inaccessible clinical insights available through selected, therapeutic-area relevant digital endpoints


Real-World Digital Measures

Physical activity, sleep, gait, mobility, and/or vital sign measures capable of being captured in a patient’s natural environment


Regulatory Guidance

Related regulatory guidance and usability validation in a specific therapeutic area

Indication Guide: Dermatology


Indication Guide: Heart Failure

Heart Failure

Indication Guide: Neuromuscular Disorders

Neuromuscular Disorders

Indication Guide: Respiratory


Indication Guide: Rheumatology



Pioneering the Digital Transformation of Clinical Research